The Departmental Research Center for Medical Laboratory Biotechnology was established to develop advanced medical technologies and apply them to be used in clinical services.

The center was divided into three groups: Infectious diseases, Metabolic diseases and Cancers.  Each group offers laboratory techniques in its specific areas.

The Infectious Diseases group focuses on analyses of bacterial antibiotic resistances, bacterial epidemiologies, environmental and food microorganisms, fungus identifications; detection of the hepatitis B virus pre- S mutant surface gene by biochip, laboratory diagnosis for viral infections, antibody analysis of influenza virus and enterovirus 71, drug resistance analysis of influenza virus, antiviral screening for influenza virus and enterovirus 71.

The Metabolic Diseases group aims to develop new bio-markers for metabolic disorders, including analyses of blood homocysteine levels, amino acid profiles, DNA methylation quantitation, and 8-hydroxyguanine DNA lesion detection.

The Cancers group focuses on tumor markers by advanced molecular diagnosis, including detection of k-Ras expression by real-time RT-PCR, analyses of immunoglobulin and T-cell receptor  clonalities. It also offers analyses on genetic polymorphisms in a number of oncogenes or tumor suppressors, such as estrogen recep.tors and a number of DNA repair genes